Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Paladin returns Canadian DepoCyt rights to SkyePharma

Dec. 13, 2002

TLK-286 enters two new combination trials

Dec. 13, 2002

Telomerase inhibitors under study at Pharmacia

Dec. 13, 2002

Inhibition of Src tyrosine kinases as a novel approach to the treatment of CML

Dec. 12, 2002

Exherin cleared to enter phase I trials in Canada

Dec. 12, 2002

NanoCarrier and Kirin collaborate on anticancer therapeutics

Dec. 12, 2002

Apomine as a new therapeutic approach to multiple myeloma

Dec. 12, 2002

New caspase activators in Cytovia development pipeline

Dec. 12, 2002

Pipecolinate MDR modulators effective in modulating mitoxantrone efflux from AML cells

Dec. 11, 2002

HDAC inhibitor active against multiple myeloma in vitro and in animal model

Dec. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...